Alignment of stakeholder agendas to facilitate the adoption of school‐supervised asthma therapy
| Autor: | Nancy Byatt, Raphael Mizrahi, Wanda Phipatanakul, Kathleen Biebel, Michelle Trivedi, Stephenie C. Lemon, Shushmita Hoque, Janki Patel, Lynn B. Gerald, Lori Pbert, Milagros C. Rosal |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine medicine.medical_specialty Adolescent Health outcomes Article Medication Adherence 03 medical and health sciences 0302 clinical medicine Adrenal Cortex Hormones Stakeholder Participation Phone 030225 pediatrics Administration Inhalation medicine Humans Child Pediatric asthma School Health Services Asthma Protocol (science) Asthma therapy Schools business.industry Stakeholder medicine.disease respiratory tract diseases 030228 respiratory system Family medicine Pediatrics Perinatology and Child Health Female business Qualitative research |
| Zdroj: | Pediatr Pulmonol |
| ISSN: | 1099-0496 8755-6863 |
| DOI: | 10.1002/ppul.24611 |
| Popis: | BACKGROUND: School-supervised inhaled corticosteroid (ICS) therapy improves pediatric asthma medication adherence, outcomes, and morbidity. However, school-supervised ICS therapy has not been widely adopted into practice. We developed Asthma Link™ as a sustainable, low-cost model of school-supervised asthma therapy, designed for real-world adoption. Initial outcomes of Asthma Link™ demonstrated a significant improvement in health outcomes. OBJECTIVE: In this study, we examined the perspectives of Asthma Link™ participants to identify systems-level barriers and facilitators in order to refine the Asthma Link™ protocol and facilitate real-world uptake of school-supervised asthma therapy. METHODS: Using qualitative research methods, we interviewed 29 participants in Asthma Link™ from 2016–2018. Semi-structured interviews were conducted over the phone. Interviews were transcribed and the transcripts were coded to identify major themes within and across stakeholder groups. RESULTS: Stakeholders agreed on many facilitators for successful Asthma Link™ execution including the brief and easy to follow procedures and the perceived beneficial health impacts for children involved. Some of the barriers identified were deviations from the protocol and insurance companies denying coverage for two inhalers. However, the participants did propose solutions to address these barriers. CONCLUSION: Asthma Link™ is a low-cost, sustainable model of school-supervised asthma therapy that leverages the established infrastructure and collaboration of medical providers, school staff, and families. In this study, we elicited the perspectives from these stakeholder groups and identified agreement in several facilitators, barriers, and proposed solutions that will ultimately inform refinement of the program protocol and support real-world adoption of Asthma Link™ and other similar models. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text